Introduction
============

Structurally diverse compounds from natural products have historically been used as therapeutic agents for disease control and prevention and as a fertile source of lead compounds for the development of novel drugs ([@B10]). However, a more thorough use of natural products for drug discovery is hampered by a lack of a complete mechanistic understanding of their pharmacological functions. With the rising of natural products as drug candidates, comprehensively determining small molecule compound--target interaction profiles have become increasingly necessary. Target and mechanism study of natural products is a central requirement for understanding the complexity of natural products and developing new drugs ([@B54]). Traditionally, identification strategies of targets have included genomic, biochemical and chemical biology-based approaches ([@B14]). However, more alternative theoretical and practical approaches are still required to better honed for natural product discovery.

To comprehensively understand the pharmacological functions of natural products, we for the first time proposed a new therapeutic concept "network target," a core idea that is distinct from the current "one target, one drug" paradigm often associated with reductionist medicine ([@B27]; [@B30]). From the perspective of the network target, natural products can target a biological network of several key molecules that derived from the multi-target nature of traditional medicine ([@B31]; [@B26]). The network target concept represents a description of complex mechanism of drug action, which suggests that the action of many small molecule compounds may have diverse effects on many proteins, leading to a perturbation of biological networks at different levels (including changes in gene expression, post-translational modifications, protein--protein interactions and metabolites) ([@B29]). Furthermore, the enriched biological processes associated with a set of interacting targets in a perturbed network target can be used to unveil the pleiotropic effects of natural products ([@B25]; [@B33]). At the same time, the network pharmacology is evolving as a holistic strategy for drug research and development by integrating information science and systematic medicine ([@B16]; [@B28]). Recent advances in experimental and computational strategies, such as chemogenomics and *in silico* approach, have provided big biological data of natural products toward network pharmacology, yielding important insights into pharmacological actions ([@B4]; [@B65]; [@B41]) and toxicological effects ([@B58]). Accordingly, the network-target-based network pharmacology for a natural product is now critical to provide precise and complete functional characterization that could be useful for drug discovery and development.

Recently, a proven group of Chinese patent medicines has held and still holds an important position in the treatment of a variety of cancers in China, and statistical analysis results from nationwide medical insurance data have suggested that *Sophorae Flavescentis Radix*, namely *Ku-Shen*, is widely used in the treatment of a variety of cancers in China ([@B52]). Matrine is a main active constituent in *Ku-Shen* which has been approved as herbal medicine in China, and has polypharmacology including anti-inflammatory ([@B57]; [@B50]), anti-tumor ([@B51]), anti-angiogenic ([@B24]) and so on. It is a kind of quinolizidine alkaloid compound and very similar in structure to oxymatrine and sophoridine. Yet, despite considerable previous research and development efforts to date, functional characterization of matrine endures a wonderful and complex challenge for pharmacologists.

Trying to approach the comprehensive mechanisms of matrine, here we took a systematic approach based on targets prediction and network target analysis to identifying the network target and functional characterization of matrine. Taking advantage of the extensive literature and experimental evidence, we systematically examined the effects of matrine on different biological processes involved and identified the network target of matrine. The influence of network target by matrine offers a unified molecular mechanism for the diverse pharmacological actions of matrine. Our preliminary evidence also revealed a previously unknown activity of matrine, induction of macropinocytosis, which has important implication in the therapeutic efficacy of *Ku-Shen*.

Materials and Methods {#s1}
=====================

Computational Procedure
-----------------------

### Target Prediction, Network Target and Functional Enrichment Analysis for Matrine

The potential targets were predicted by the drugCIPHER-CS method ([@B66]). The drugCIPHER-CS method uses a regression model to predict relationships between compounds and proteins by correlating the closeness of the global pharmacological network and the protein--protein interaction network. DrugCIPHER-CS calculated the correlation between the chemical similarity vector of matrine-seed drugs and drug-protein closeness vector as the likelihood of the interactions of drug-target. Accordingly, we define the similarity vector **CS**~d~ for matrine *d* as {*CS*~dd1~, *CS*~dd2,~ ..., *CS*~ddn~} and extend equation (1) into:
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where *d*~j~ is the known drug *j* binding to the given protein *p*. β′~p~ and α′~pdj~ are the model coefficients. The likelihood between matrine *d* and protein *p* is defined as concordance score:
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According to the concordance score of each target protein for matrine, drugCIPHER-CS prioritizes the proteins in the PPI network, and the candidate proteins with high concordance score are hypothesized to be predicted targets of matrine with high confidence.

As the top 100 predicted targets of drug prediction can achieve the high prediction accuracy (77.3%), the network target of matrine is composed of the top 100 predicted targets of matrine in the protein--protein interaction network ([@B66]). To gain insight into the detailed functions of the matrine, we examined the overrepresented biological processes of the network target of matrine using the Database for Annotation, Visualization and Integrated Discovery (DAVID) ([@B17]). The network target of matrine was mainly examined for enrichment Gene Ontology (GO) biological process (BP) (Supplementary Table [S1](#SM1){ref-type="supplementary-material"}) ([@B2]). Here, we reserved all the enriched biological processes. The steps for constructing BP network were depicted as followed. First, PPI network was generated with 137,037 interactions among 13,388 ([@B66]). Then, we used gene sets of enriched biological processes of matrine to generate a sub network. Finally, an edge will be added between two classes of biological processes if there are shared genes in two classes.

Experimental Validation
-----------------------

### Reagents and Cell Culture

Matrine and amiloride hydrochloride was purchased from Sigma (Shanghai, China). Lucifer yellow (LY), pHrodo^TM^ Green Dextran and Alexa Fluor^®^488 Phalloidin were purchased from Invitrogen (Shanghai, China). EIPA was purchased from Tocris. HepG2, PLC, HCT-8, HCT-116, HT29 and DLD-1 were obtained from ATCC (American Type Culture Collection, Rockville, MD, United States).

### Transmission Electron Microscopy

Human colon cancer DLD-1 cells were exposed to 1.25, 2.5 and 5 mM matrine for 12 h and then fixed, dehydrated, and infiltrated for Transmission Electron Microscopy (TEM) as described previously ([@B22]). Ultrathin sections were collected on copper 300-mesh support grids, stained with uranyl acetate and lead citrate, and examined under a Hitachi H-7650B TEM.

### Time-Lapse Microscopy

DLD-1 cells (200,000 cells) were plated in a 35-mm glass-bottom microwell culture dish. One day after plating, cells were treated with 5 mM matrine in RPMI-1640 medium with 10% FBS. The dish was immediately placed in a humidified Live Cell chamber (Pathology Devices, Westminster, MD, United States) equilibrated with 5% CO~2~ at 37°C. The chamber was placed on the stage of a Nikon Eclipse Ti inverted microscope, equipped with a digital camera and Slide-book software (Intelligent Imaging Innovations, Inc., Denver, CO, United States). The software was set to automatically acquire phase-contrast images every 1 s for the indicated period of time.

### The Uptake of Fluid-Phase Fluorescent Tracers

Labeling of endocytic compartments with these fluid-phase tracers was performed as previously described ([@B39]). Briefly, cells were incubated with LY (500 μg/ml in the phenol red-free DMEM containing 10% fetal bovine serum) and pHrodo^TM^ Green dextran (50 μg/ml in the same medium) for 5 h and 10 h in a 37°C, 5% CO~2~ incubator, respectively. The tracer was removed and the cells were washed once or twice with the medium. Phase-contrast and fluorescent images of the living cells were acquired on a Nikon Eclipse Ti fluorescence microscope with a digital camera and NIS-Elements AR software (Nikon Instruments, Inc., Melville, NY, United States).

### Confocal Fluorescence Microscopy

For colocalization experiments, DLD-1 cells that had been treated with matrine were prepared for immunofluorescence microscopy as described previously ([@B22]). Phalloidin-FITC to detect cytoskeletons was purchased from Sigma. The cells were examined by Nikon A1+/A1R+ confocal microscopy.

### Treatment of Cells with EIPA and Amiloride

To inhibit macropinocytosis, DLD-1 cells were washed twice with PBS and then pretreated for 30 min with RPMI-1640 + 0.5% BSA in the presence or absence of 50 μM EIPA or 4 mM Amiloride. Following pretreatment, matrine was added to the dishes at a final concentration of 5 mM and phase-contrast images were acquired 5 h later.

### Statistical Analysis

At least three independent experiments were conducted in each study. The values are expressed as the means ± SEM. A two-tailed *t*-test was performed to determine the statistical significance. *P* \< 0.05 was considered significant.

Results
=======

The Network Target and Literature Validation of Matrine
-------------------------------------------------------

Actually, matrine is one of several alkaloids in *Ku-Shen* that has not only been experimentally shown to cause a neurotoxic response, but has been shown to exert neuropharmacological activities, e.g., antinociceptive effects, hypothermic actions, neuroprotective role, antiepileptic effects, sedative effects, memory enhancement and sleep improvement. In addition, matrine may serve other pleiotropic functions, such as immunological regulation, anti-inflammatory activity, cardiac effects and anti-tumor effect (Supplementary Table [S1](#SM1){ref-type="supplementary-material"}). Therefore, we hope to construct a simple, rapid and lower-cost strategy on overall interpretation of biological functions of natural products like matrine. Here, the network target of matrine was performed by our network-based method drugCIPHER ([@B66]). We selected top 100 predicted targets in the protein--protein interaction network as the network target of matrine. Further, we examined the overrepresented ontological terms of the network target using enrichment analysis ([@B17]). Expectedly, the most representative GO BP terms of the network target of matrine include "neurological system process," "sensory perception of pain," "learning or memory," "immune response," "inflammatory response," "regulation of heart contraction," "tissue remodeling," "ion homeostasis," "regulation of lipase activity," "regulation of blood pressure," "response to oxidative stress," "regulation of cell proliferation," "regulation of apoptosis," "cell migration," "angiogenesis," "leukocyte differentiation," and "viral reproduction," thus validating the reliability of the predicted targets given the well-documented pharmacological and biological effects of matrine (**Figure [1A](#F1){ref-type="fig"}**).

![Target prediction results of matrine and extensive literature verification. **(A)** Matrine-targeting molecular network with annotation labels comprising GO BP classes. **(B)** The coverage rate of the predicted targets of matrine toward reported biomolecules, which was calculated by \[the intersection of the predicted targets and reported biomolecules/the number of reported biomolecules\] × 100%. There are two main relationships between the predicted targets and reported biomolecules, direct and indirect association. Direct association represents that the predicted targets are identical with reported biomolecules. Indirect association represents that the predicted targets are linked to reported biomolecules by protein--protein interactions or pathways.](fphar-09-00010-g001){#F1}

It is true that bioactive natural products can essentially regulate a molecular network by binding multiple targets, which may imply possible multiple effects. Therefore, to obtain a comprehensive functional characterization of matrine, we firstly validated the reliability of the predicted molecular network regulated by matrine. Here, we searched for reported molecular mechanisms related to matrine from Pubmed and CNKI database by the way of literature mining. The predicted targets of matrine can be connected to its reported biomolecules by direct or indirect targeting (protein--protein interactions or signaling pathways) ([@B42]). The results suggested that the predicted targets of matrine can be related to the molecular mechanisms reported in the literature. The statistical results showed that the predicted targets of matrine can cover 86.4% of the reported molecular mechanisms and the reliability of the predicted targets of matrine was found to be very high, which can be used for the comprehensive functional characterization of matrine (**Figure [1B](#F1){ref-type="fig"}**).

Comprehensive Functional Assignment and Preliminary Validation of Matrine
-------------------------------------------------------------------------

It has been reported that matrine possesses a variety of pharmacological effects. Besides, oral administration of large doses of *Ku-Shen* is reported to cause toxicity and side effects, including salivation, tachycardia and abnormal gait ([@B12]). Larger doses that induce more severe poisoning may result in central nervous system (CNS) excitement with muscle spasm and seizures, followed by signs of CNS (primarily respiratory) depression with a decreased respiratory rate and promotes oligodendrocyte development, potentially progressing to apnea ([@B19]; [@B35]). Therefore, we need to provide an analysis strategy based on the network target of matrine that derive a set of biological functions for revealing the bioactive diversity and side effects of matrine.

To explore comprehensively functional annotations of the matrine, all of enriched terms, regardless of *P*-value, are shown in Supplementary Table [S1](#SM1){ref-type="supplementary-material"}. Enrichment analysis results showed that the network target of matrine are involved in neurological system processes, which may substantially disturb these biological processes. Indeed, the top 10 GO BP terms in the functional enrichment list significantly focused on nervous system, for example, synaptic transmission (*P* = 1.41E-15) as well as the transmission of nerve impulses (*P* = 2.92E-15). The results of literature validation suggested that many enriched biological processes have been reported in the literature (**Table [1](#T1){ref-type="table"}**). Further, to evaluate this enrichment results, we manually collected 101 literatures related to biological processes of matrine. The results showed that 90.1% of reported biological processes were covered by enriched biological processes of the network target of matrine (**Figure [2A](#F2){ref-type="fig"}**). The representative biological functions of matrine are summarized in **Table [1](#T1){ref-type="table"}** and **Figure [2B](#F2){ref-type="fig"}**. Anti-tumor effect, anti-viral effect, lipid metabolism, cardiovascular and blood pressure-lowing effect in the enriched biological functions of predicted targets of matrine are completely supported by literature evidence. Other important enriched biological functions of matrine can also be partly validated. These results suggested that featured as high-throughput, computational and capable of rapid analyses, our network pharmacology approach would have a strong potential to be applicable to other natural products for precise and comprehensive functional characterization.

###### 

Enriched biological processes of predicted targets for matrine.

  Biological process class                         Gene ontology term                      Reference
  ------------------------------------------------ --------------------------------------- -----------
  Neuroprotective or neurotoxic effect             Synaptic transmission                   [@B55]
                                                   Neurological system process             [@B37]
                                                   Glutamate signaling pathway             [@B63]
  Analgesic effect                                 Sensory perception of pain              [@B47]
  Memory enhancement and sleep improvement         Learning or memory                      [@B11]
                                                   Rhythmic process                        [@B34]
  Lipid and energy metabolism                      Fatty acid metabolic process            [@B56]
                                                   ATP metabolic process                   NA
  Pharmacological action on ion channel            Ion transport                           [@B49]
  Anti-inflammatory and immunological regulation   Inflammatory response                   [@B57]
                                                   Lymphocyte activation                   [@B67]
  Cardiovascular effect                            Regulation of catecholamine secretion   [@B48]
                                                   Tissue remodeling                       [@B64]
  Anti-viral effect                                Viral reproduction                      [@B23]
  Vesicle formation and endocytosis                Membrane invagination                   NA
                                                   Endocytosis                             NA
  Anti-tumor effect                                Regulation of cell proliferation        [@B32]
                                                   Biological adhesion                     [@B60]
                                                   Angiogenesis                            [@B36]
                                                   Cell migration                          [@B46]

![Literature verification of the GO terms in BP category at all levels enriched from the network target of matrine. **(A)** The coverage rate of potential biological processes with literature evidence for matrine, which is defined as \[the intersection of reported GO terms and enriched GO terms/the number of reported GO terms\] × 100%. **(B)** Pie chart for the coverage rate of enriched GO terms in different classes from predicted targets of matrine covered by known biological processes of matrine. The coverage rate of each sector is calculated by \[the intersection of reported GO terms and enriched GO terms/the number of enriched GO terms in one class\] × 100%.](fphar-09-00010-g002){#F2}

Multiple and complex actions of natural products can be described in terms of molecular networks capturing the intricate web of connections among their targets ([@B5]). To further explore the functional characterization of matrine on a large scale, we constructed an enriched functional network for better interpreting the global functional connections of matrine (**Figure [3A](#F3){ref-type="fig"}**). The structure of this functional network shown that known and novel GO BP functions share the same molecular mechanisms. Despite being a drug with well-characterized pharmacological actions, matrine has never been previously linked to ATP metabolism and membrane organization/endocytosis. To verify the effect of matrine on the ATP metabolism, we evaluated the ATP levels in the DLD-1 cells treated with matrine by a well-established assay for the levels of ATP. Following treatment with matrine, we observed the decrease of cellular ATP level in a concentration-dependent manner as shown in **Figure [3B](#F3){ref-type="fig"}**.

![Identification and preliminary validation of novel functions of matrine. **(A)** Biological process network represents the comprehensive functional characterization of matrine using our network pharmacology approach. Blue nodes represent unreported biological processes of matrine. **(B)** Dose-effect relationship of matrine on cellular ATP level. **(C)** The endocytosis-associated network module of matrine with expression in different cancer cell lines. **(D)** Cell phenotype changing after different cancer cells treated with matrine (1.25--5 μM).](fphar-09-00010-g003){#F3}

Based on the molecular network regulated by matrine, we tried to infer the response of different cancer cell lines to endocytosis induced by matrine. We extracted the mRNA expression data of hepatocellular and colorectal cancer cell lines from the Cancer Cell Line Encyclopedia ([@B3]). The result demonstrates that genes in endocytosis-associated network module of matrine are expressed more highly in DLD-1 cell line (**Figure [3C](#F3){ref-type="fig"}**). Then, we examined whether induction of cytoplasmic vacuolization by matrine is cell-specific. Therefore, we performed the same treatment experiments in various cancer cell lines. Strikingly, we observed more significant morphological changes with increasing concentrations of matrine in the DLD-1 than other cancer cell lines (**Figure [3D](#F3){ref-type="fig"}**).

Matrine as a Novel Macropinocytosis Inducer in Cancer Cells
-----------------------------------------------------------

In fact, previous studies have demonstrated that matrine increases the cell volume and induces the formation of abundant cytoplasmic vacuoles in the SGC-7901 human gastric cancer cells and human hepatoma G2 cells ([@B62]; [@B59]), but how these vacuoles are formed is not fully understood. To further verify the effect of matrine on the regulation of membrane organization, we set out to determine the membrane changes in different cancer cells treated with matrine and also observed vesicle formation by endocytosis.

The endocytosis-associated network module of matrine with expression in DLD-1 is shown in **Figure [4A](#F4){ref-type="fig"}**. The results suggest that high expression of these predicted targets of matrine in DLD-1 cells is associated with biological response to matrine. Therefore, observation of DLD-1 cells with standard phase contrast optics and a transmission electron microscope revealed that the biological processes initiated by the addition of matrine at increasing concentrations (1.25--10 mM) to DLD-1 cells within 24 h involve massive membrane ruffling and blebbing as well as cell rounding, followed by the formation of vacuoles that increase in number and size in a concentration-dependent manner (**Figures [4B,C](#F4){ref-type="fig"}**). 5 mM matrine was selected for further study because this concentration yielded the most significant number of vacuoles. Time-lapse phase-contrast microscopy was also used to capture the dynamic changes of cytoplasmic vacuolization over time within 6 h and found that nascent vesicles could fuse with each other to form progressively larger vacuoles within the cytoplasm (**Figure [4D](#F4){ref-type="fig"}**). The results confirm the induction of endocytic-like activity by matrine. Since macropinocytosis is defined as the formation of large endocytic vesicles of irregular sizes and shapes by cells that avidly incorporate extracellular fluid ([@B44]; [@B21]), we reasoned that this cellular process mediated by matrine could be macropinocytosis.

![Matrine induces vesicle formation, endocytosis and macropinocytosis in a time-and concentration-dependent manner. **(A)** The endocytosis-associated network module of matrine with expression in DLD-1. **(B)** Phase-contrast microscopy of the matrine-treated DLD-1 cells for 12 h shows extensive accumulation of cytoplasmic vacuoles and cell detachment in a concentration-dependent manner. **(C)** TEM images of matrine-treated DLD-1 cells at different concentrations for 12 h. Red arrow points at cytoplasmic vacuoles. Bar, 10 μM. **(D)** Live imaging of DLD-1 cells (5 mM matrine). Images collected at times of major phenotypic changes.](fphar-09-00010-g004){#F4}

Matrine-Induced Vacuoles Are Macropinosomes
-------------------------------------------

Macropinocytosis is known to be a form of actin-dependent endocytosis that leads to the internalization of fluid and membranes into large vesicles as macropinosomes. Next, we tested whether the large vesicles induced by matrine are consistent with the typical characteristics of macropinosome. As we know, rapid incorporation of extracellular-phase fluid tracers is a hallmark of macropinosomes ([@B44]). Therefore, to confirm that the vacuoles were derived from macropinosomes, DLD-1 cells were subjected to short-term incubation with a bulk fluid-phase tracer, FITC-dextran, together with matrine. Our results showed that the uptake of FITC-dextrans by the vacuoles was almost equal during the 5 mM matrine treatment, indicating that the origins of many of these vacuoles could be macropinosomes (**Figure [5A](#F5){ref-type="fig"}**). To further confirm that the matrine-induced vacuoles observed by phase-contrast microscopy were indeed derived from macropinosomes, DLD-1 cells were incubated with the tracer LY during the first 5 h after the addition of matrine. As shown in **Figure [5B](#F5){ref-type="fig"}**, LY was also incorporated into most of the phase-lucent vacuoles. After fixing and staining with rhodamine-phalloidin, phalloidin counterstaining on DLD-1 cells shows that matrine disturbed the actin filament cytoskeleton of DLD-1 cells (**Figure [5C](#F5){ref-type="fig"}**). Macropinocytosis can be distinguished from some types of endocytosis by its susceptibility to EIPA and amiloride (inhibitors for Na+/H+ exchangers). We investigated the effects of EIPA and amiloride on macropinocytosis in DLD-1 cells. **Figures [5D,E](#F5){ref-type="fig"}** show that the cytoplasmic vacuolization during the 5 mM matrine treatment was markedly inhibited by 50 μM EIPA and 4 mM amiloride, respectively. We concluded that the origin of a substantial portion of the cytoplasmic vacuoles was macropinocytosis. These results demonstrated that macropinocytosis was involved in matrine-induced vacuolization and verified the efficiency of our computational method.

![The vacuoles were derived from macropinosomes. **(A)** Vacuolated cells were preincu-bated with FITC-dextran (green). Arrowhead points to a FITC dextran-containing vacuole. **(B)** LY accumulation in DLD-1 cells (green). Arrowhead points to a LY-containing vacuole. Macropinocytosis index (MI) was ^∗∗^*P* \< 0.01, compared with control. **(C)** DLD-1 cells were stimulated with 5 mM matrine. Nuclei were stained with DAPI (blue), and cells were stained for actin with rhodamine-phalloidin (red). **(D)** Effect of EIPA on matrine-induced macropinocytosis. **(E)** Effect of amiloride on matrine-induced macropinocytosis.](fphar-09-00010-g005){#F5}

Macropinocytosis plays an important role in multifunctional biological processes, such as nutrient supply and non-apoptotic death of tumor cells ([@B9]; [@B22]).

Discussion
==========

Experimental methods for target identification of natural products have had substantial success, yet many limitations still remain, including a high false-positive rate and bioactivity changes in labeled ligands ([@B43]; [@B45]). In recent years, many computational methods and algorithms have been developed to predict target profiles, such as phenotypic effect-based ([@B40]; [@B6]) and chemical structure-based approaches ([@B20]). [@B18] developed a computation approach to predict drug effect similarities and modes of action using 'consensus' transcript signatures following compound treatment. However, their method is largely dependent on drugs with known transcriptional signatures, therefore limiting the application of this system in high-throughput compound screening. [@B7] proposed different methods to predict drug-target interactions and demonstrated that network-based methods achieved the best performance in benchmark tests ([@B7]). Nevertheless, their method only considers proteins that are known targets. To identify global targets of natural products, we used a network-based target prediction approach, which is not limited to the structural information of target proteins and requires the chemical structure of natural products. This computational approach can meet the characteristics of mechanism of natural products. More broadly, we can also extend the application of our general network-based approach to identifying pharmacological functions of full-scale ingredients from one herb.

Several alkaloids, as the main active constituents of *Ku-Shen*, have been approved as drugs, including matrine, oxymatrine, and sophoridine. In fact, the biological activities of matrine are more relevant to other applications of *Ku-Shen* other than anti-tumor activities. It is reported to possess a variety of pharmacological activities, including antipyretic ([@B8]; [@B53]), antiepileptic ([@B53]), antinociceptive ([@B47]; [@B13]), anti-inflammatory ([@B57]; [@B50]), myocardial preservation ([@B64]), antifibrotic ([@B61]), anti-tumor ([@B51]), anti-viral ([@B23]) and anti-angiogenic ([@B24]). Our predicted results demonstrated that matrine could target a molecular network related to multiple functions, which is consistent with the multi-target nature of traditional medicine. Therefore, matrine regulates ATP metabolism and the induction of vesicle formation and endocytosis by regulating the network target of matrine. The pharmacological functions of matrine based on network target and experimental verification reveal that the biological processes initiated by matrine involves massive membrane reorganization and cell rounding, followed by vacuole formation, which is a typical macropinocytosis process. Recently, macropinocytosis has been reported to be involved in the phagocytosis of apoptotic cells and promote the resolution of inflammation ([@B15]; [@B38]). Moreover, the small GTPase Rac1, which mediates the formation of the initial membrane ruffles and macropinosomes, is crucial for mammary alveolar epithelia to switch from secretion mode to phagocytic mode to rapidly remove dying neighbors and inhibit chronic inflammation ([@B1]). Therefore, a novel anti-inflammatory mechanism of matrine may be associated with the clearance of apoptotic cells by the macropinocytosis process. This finding can be used to better elucidate the "clearing hot" efficacy of *Ku-Shen* in TCM.

In order to further obtain the evidence of the mechanism of matrine, the observation that amiloride and EIPA can attenuate the macropinocytosis induced by matrine suggested that its mechanism may be correlated with the proton channel. The genes related to Vesicle formation and Endocytosis in the network target of matrine are APP, GRIA2, GRIA1, ATP5B, DLG4, MERTK, THBS1 and the genes in Endocytosis-associated module also include SCEL, THBS1, CORO1A, CXCL5, CLU, and SH3GL2. Therefore, we inferred that matrine-induced macropinocytosis occurs through ATP5B signaling or GRIA2 and GRIA1. These hypotheses need to be further validated prospectively.

In summary, we developed a network target strategy for comprehensive functions of matrine in a Chinese medical herb, Sophorae Flavescentis Radix (*Ku-Shen*), and provided experimental evidence to demonstrate the availability of a network-target-based approach. The network target regulated by matrine provides evidence for the diverse functions of matrine in *Ku-Shen* and shows that matrine can induce macropinocytosis in cancer cells and can decrease cellular ATP level. Our general network-based approach to fully elucidate comprehensive functions of matrine can be applied to many other natural products for the identification of their pharmacological functions.
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